Ultragenyx to Present at the JMP Securities Healthcare Conference

June 18, 2014 1:03 PM

5 0

Ultragenyx Pharmaceutical Inc. /quotes/zigman/24582850/delayed/quotes/nls/rare RARE +5.38% , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer, will be presenting at the JMP Securities Healthcare Conference on June 25, 2014 at 2:30pm ET at the Westin New York Grand Central.

The live and archived webcast of the company presentation will be accessible from the company's website at http://ir.ultragenyx.com/events.cfm . The replay of the webcast will be available approximately one hour after the conclusion of the live presentation and will be available for 180 days.

Read more

To category page

Loading...